Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07431125

Surgical-Clinical Correlation in Unilateral Conductive Hearing Loss With Intact Tympanic Membrane

Conditions: Conductive Hearing Loss, Unilateral

Sex: All
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: Al-Azhar University

Location: Alazhar university Hopital in Assiut Asyut Asyut Governorate

Summary

Unilateral conductive hearing loss (UCHL) in the presence of an intact tympanic membrane represents a diagnostic challenge in otologic practice. In the absence of middle ear effusion or tympanic membrane pathology, stapes fixation secondary to otosclerosis is often considered the most probable diagnosis. However, although otosclerosis is traditionally regarded as a bilateral disease, clinical presentation may be unilateral due to asymmetric disease progression or subclinical contralateral involvement. Other etiologies, including congenital ossicular anomalies, ossicular discontinuity, tympanosclerosis without tympanic membrane involvement, or oval window abnormalities, may mimic otosclerosis both clinically and audiologically. Consequently, exploratory tympanotomy remains the gold standard for definitive diagnosis, allowing direct assessment of ossicular chain mobility and confirmation of stapes fixation. Correlating preoperative clinical suspicion with intraoperative findings is therefore essential to better define the true causes of unilateral conductive hearing loss with an intact tympanic membrane.

Eligibility Criteria

Inclusion Criteria: * unilateral conductive hearing loss or mixed HL with intact Tympanic Membrane * Average Airborne Gap Above 20 decibels Exclusion Criteria * Sensorineural hearing loss * Chronic otitis media * TM perforation * Previous ear surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07431125). StuddyBuddy aggregates publicly available trial information.